Synonym: 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinic acid; 6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid; AGN 190299; AGN-190299; Tazarotene acid
CAS Number: 118292-41-4
Empirical Formula (Hill Notation): C19H17NO2S
Molecular Weight: 323.41
MDL Number: MFCD00872121
Linear Formula: C19H17NO2S
Product Type: Chemical
assay |
≥98% (HPLC) |
color |
white to light brown |
form |
powder |
InChI |
1S/C19H17NO2S/c1-19(2)9-10-23-17-8-4-13(11-16(17)19)3-6-15-7-5-14(12-20-15)18(21)22/h4-5,7-8,11-12H,9-10H2,1-2H3,(H,21,22) |
InChI key |
IQIBKLWBVJPOQO-UHFFFAOYSA-N |
Quality Level |
100 |
SMILES string |
CC1(C)CCSC2=C1C=C(C#CC3=CC=C(C(O)=O)C=N3)C=C2 |
solubility |
DMSO: 20 mg/mL, clear |
storage temp. |
2-8°C |
Biochem/physiol Actions: |
Tazarotene is transformed to tazarotenic acid with the help of esterases. Tazarotenic acid regulates the pathogenic aspects of psoriasis through normalizing abnormal keratinocyte differentiation. It possesses strong anti-hyperproliferative effects in skin and reduces inflammation. |
Biochem/physiol Actions: |
Tazarotenic acid, an active metabolite of tazarotene, is a potent and selective agonist of the retinoid receptor (RAR) that binds to RARα, RARβ, and RARγ. Tazarotenic acid relatively selective activates RARβ and RARγ. Tazarotenic acid is a first xenobiotic substrate of human retinoic acid hydroxylase CYP26A1 and CYP26B1. |
Packaging: |
5, 25 mg in glass bottle |
RIDADR |
NONH for all modes of transport |
WGK Germany |
WGK 3 |
Flash Point(F) |
Not applicable |
Flash Point(C) |
Not applicable |
Purity |
≥98% (HPLC) |
Storage Temp. |
2-8°C |
UNSPSC |
12352106 |